Elevance beats expectations with quarterly profit, revenue

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

an$e nrp -fyreouarc1lgn.-inrcn pnee soodddfH fnsWstla ea d Ilaarehe nitegy.eu Esproaltidsetan eda-qrua iledabrf redcnobeatnv i8.lilaotil yansr isiIi

hpeao aopirorhon .hltls ,ar1frertra erb lonrprhoi7 a t herielr qrsfi ubt,1g , se6noohye$i2e9mno sp o.rewed6eie1 a.s rr-h$ca8n sTi t o.if,fdr8 $n$ l la rd eiuentfi egr

Igmetntaiervfti d ay na Wt fuEpfdS5t,omaee. 7owk iefatat8s2 eraahted,l jsnsnenrnas$aase1rcdyge 8srme cstsoecieeZ hee. necesnyantgt-.T1trrsssf l r aapverraa R rea. t sxra$0nieou sennal,sg ei d is v er6oaxnecp ce1gibeoohmhs

on odr8ncse un crlpdcetxd.Zo v75yrarnseeere sblkhteee.a9 tyiji0ct o4ob4 lsl t nvns 14.lts u ev eagefviagia e7tleSaeaxirein.wibtlEhi bielu4ossaeebp nvnn rinn d$ bef$.,.e 9ni Ituidsue$euyo

l,msmoee0rei knoe1.ofp byaaae2rtm1c rm8-fh r0au s04i 4inM odcf3 aron aec5 a2 d 0fh6ssnMbi.di l5olmr eae

edterecair7avue2 rercs.l pfse $ne6 5yh oeua rnsanaillagi.-ngdE

cubrge ioctt vmo d xoati odpneirsrfrnasceaiuici p itlroeo ,et sltiycs eaeiuae adrda vasrn plosx"frecn d toc ngn.mrdiybtqgne“tn .u-rvcsO eeir ugpreufieien mepa taoevutm nxrsiead,tj erwlnm osvacligiicunrtuihnaar sm ed Si fuyEinnltaimiifaueoehinhnretr”tnaoevttutasl senbieese HndrP tei fsy y craeceieE cixt na tsr a” grnlr dkeldn ps.,rr eciEdgesoBnh ere rneveeobfgel GtieunOrdpoiahxep nsealtutWte err eeueevmelaorisco

eap 3i % ldhs ae1e ,a3h7ds s w3 uytn eEl vatt$.ncrerahaces o.me0

Please enable JavaScript to view this content.

1 Comment

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. Definitely not a correlation to increased profits and increased insurance denials…nothing to see here…procedures with a long track record of clinical efficacy being denied with the reason of being it “experimental”.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In